Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder

por Cannon, DM, Klaver, JK, Gandhi, SK, Solorio, G, Peck, SA, Erickson, K, Savitz, J, Akula, N, Eckelman, WC, Furey, ML, Sahakian, BJ, McMahon, FJ, Drevets, WC
Publicado 2010

Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder

por Schulze, TG, Detera-Wadleigh, SD, Akula, N, Gupta, A, Kassem, L, Steele, J, Pearl, J, Strohmaier, J, Breuer, R, Schwarz, M, Propping, P, Nöthen, MM, Cichon, S, Schumacher, J, Rietschel, M, McMahon, FJ
Publicado 2008

Enrichment of Cis-Regulatory Gene Expression SNPs and Methylation Quantitative Trait Loci Among Bipolar Disorder Susceptibility Variants

por Gamazon, ER, Badner, JA, Cheng, L, Zhang, C, Zhang, D, Cox, NJ, Gershon, ES, Kelsoe, JR, Greenwood, TA, Nievergelt, CM, Chen, C, McKinney, R, Shilling, PD, Schork, NJ, Smith, EN, Bloss, CS, Nurnberger, JI, Edenberg, HJ, Foroud, T, Koller, DL, Scheftner, WA, Coryell, W, Rice, J, Lawson, WB, Nwulia, EA, Hipolito, M, Byerley, W, McMahon, FJ, Schulze, TG, Berrettini, WH, Potash, JB, Zandi, PP, Mahon, PB, McInnis, MG, Zöllner, S, Zhang, P, Craig, DW, Szelinger, S, Barrett, TB, Liu, C
Publicado 2012